氯喹作为 COVID-19 的预防药物？
Chloroquine as a prophylactic agent against COVID-19?
机构信息
Unité Parasitologie et Entomologie, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, Marseille, France; Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France; IHU Méditerranée Infection, Marseille, France.
Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France; IHU Méditerranée Infection, Marseille, France; Service des Maladies Infectieuses, Hôpital d'Instruction des Armées Laveran, Marseille, France.
出版信息
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
Abstract
• Efficacy of chloroquine and hydroxychloroquine in COVID-19 treatment is discussed. • Prophylactic use of chloroquine or hydroxychloroquine in COVID-19 is considered.
摘要
• 讨论了氯喹和羟氯喹在 COVID-19 治疗中的疗效。
• 考虑在 COVID-19 中预防性使用氯喹或羟氯喹。
相似文献
1
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
2
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.氯喹或羟氯喹用于预防2019冠状病毒病。
Lancet Infect Dis. 2020 Oct;20(10):1118. doi: 10.1016/S1473-3099(20)30296-6. Epub 2020 Apr 17.
3
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.羟氯喹维持治疗期间突破性 COVID-19 感染 1 例
J Korean Med Sci. 2020 Jun 22;35(24):e231. doi: 10.3346/jkms.2020.35.e231.
4
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).氯喹和羟氯喹在冠状病毒病-19（COVID-19）中的预防作用的系统评价。
Int J Rheum Dis. 2020 May;23(5):613-619. doi: 10.1111/1756-185X.13842. Epub 2020 Apr 27.
5
Hydroxychloroquine prophylaxis for COVID-19 contacts in India.印度针对新冠病毒病接触者的羟氯喹预防措施
Lancet Infect Dis. 2020 Oct;20(10):1118-1119. doi: 10.1016/S1473-3099(20)30313-3. Epub 2020 Apr 17.
6
Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?在疟疾感染率较高的国家，2019冠状病毒病（COVID-19）的发病率是否较低？
Med Hypotheses. 2020 Jul;140:109756. doi: 10.1016/j.mehy.2020.109756. Epub 2020 Apr 22.
7
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.氯喹、羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎（SARS-CoV-2感染）时的安全性考量
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
8
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
9
Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.氯喹和羟氯喹用于预防和治疗2019冠状病毒病：新希望与旧有的心血管问题
Kardiol Pol. 2020 Aug 25;78(7-8):811-817. doi: 10.33963/KP.15511. Epub 2020 Jul 14.
10
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.羟氯喹在非人类灵长类动物中对抗 SARS-CoV-2 感染的应用。
Nature. 2020 Sep;585(7826):584-587. doi: 10.1038/s41586-020-2558-4. Epub 2020 Jul 22.
引用本文的文献
1
Biophysical Analysis of Potential Inhibitors of SARS-CoV-2 Cell Recognition and Their Effect on Viral Dynamics in Different Cell Types: A Computational Prediction from In Vitro Experimental Data.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）细胞识别潜在抑制剂的生物物理分析及其对不同细胞类型中病毒动力学的影响：基于体外实验数据的计算预测
ACS Omega. 2024 Feb 14;9(8):8923-8939. doi: 10.1021/acsomega.3c06968. eCollection 2024 Feb 27.
2
Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds.计算研究苯亚苄基乙酮衍生物对 SARS-CoV-2 的作用，作为有潜力的多靶标生物活性化合物。
Comput Biol Med. 2022 Jul;146:105668. doi: 10.1016/j.compbiomed.2022.105668. Epub 2022 May 27.
3
Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions.新型冠状病毒感染患者的免疫状态在确定治疗干预疗效中的意义
J Pers Med. 2022 Feb 25;12(3):349. doi: 10.3390/jpm12030349.
4
Development and Validation of the Quantification Method for Hydroxychloroquine in Volumetric Absorptive Microsampling (VAMS) Using High-Performance Liquid Chromatography-Photodiode Array.高效液相色谱-光电二极管阵列法测定体积吸收微采样（VAMS）中羟氯喹含量的方法开发与验证
Adv Pharmacol Pharm Sci. 2021 Sep 30;2021:3500279. doi: 10.1155/2021/3500279. eCollection 2021.
5
Potential drug development and therapeutic approaches for clinical intervention in COVID-19.针对 COVID-19 的临床干预的潜在药物研发和治疗方法。
Bioorg Chem. 2021 Sep;114:105016. doi: 10.1016/j.bioorg.2021.105016. Epub 2021 May 25.
6
Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.应对 COVID-19 的潜在治疗药物：抗病毒疗法、免疫疗法和细胞疗法的最新综述。
Biomed Pharmacother. 2021 Jun;138:111518. doi: 10.1016/j.biopha.2021.111518. Epub 2021 Mar 16.
7
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
8
Association Between Self-Reported Adherence to Preventive Practices and Probability of Turning COVID-19 Positive: A Cross-Sectional Analytical Study.自我报告的预防措施依从性与新冠病毒检测呈阳性概率之间的关联：一项横断面分析研究。
Cureus. 2020 Dec 1;12(12):e11815. doi: 10.7759/cureus.11815.
9
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.COVID-19 药物再利用时肾功能和肝功能损伤患者的剂量推荐。
Drugs R D. 2021 Mar;21(1):9-27. doi: 10.1007/s40268-020-00333-0. Epub 2020 Dec 17.
10
Addressing budget reduction and reallocation on health-related resources during COVID-19 pandemic in malaria-endemic countries.在疟疾流行国家应对 COVID-19 大流行期间与卫生相关资源的削减和重新分配问题。
Malar J. 2020 Nov 16;19(1):411. doi: 10.1186/s12936-020-03488-y.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.一项关于氯喹治疗 COVID-19 的疗效和安全性的系统评价。
J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.
3
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].《磷酸氯喹治疗新型冠状病毒肺炎专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188. doi: 10.3760/cma.j.issn.1001-0939.2020.03.009.
4
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
5
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
6
Protecting Chinese healthcare workers while combating the 2019 novel coronavirus.在抗击2019新型冠状病毒的同时保护中国医护人员。
Infect Control Hosp Epidemiol. 2020 Jun;41(6):745-746. doi: 10.1017/ice.2020.60.
7
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
8
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
9
Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.阿奇霉素通过上调病毒诱导的I型和III型干扰素反应来预防寨卡病毒感染。
Antimicrob Agents Chemother. 2019 Sep 9;63(12). doi: 10.1128/AAC.00394-19. Epub 2019 Sep 16.
10
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells.阿奇霉素在人神经胶质细胞中显示出抗寨卡病毒活性。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.01152-17. Print 2017 Sep.
Zotero 插件